
Medicus Weight Loss Clinic in Marrero, Louisiana, operates under the medical direction of E. Ward Sudderth, M.D., a board-certified surgeon with specialized training in general surgery, cosmetic surgery, and medical weight loss management. Dr. Sudderth brings a surgical precision and evidence-based approach to metabolic health, understanding that sustainable weight loss requires medical intervention tailored to individual physiology rather than generic diet programs. The clinic focuses exclusively on physician-supervised weight management protocols that address the hormonal and metabolic factors underlying obesity and weight-related health conditions.
The clinic's treatment protocols center on GLP-1 receptor agonist peptide therapy, specifically semaglutide and tirzepatide injections administered under medical supervision. Semaglutide works by mimicking the glucagon-like peptide-1 hormone to regulate appetite, slow gastric emptying, and improve insulin sensitivity, while tirzepatide combines GLP-1 and GIP receptor agonism for dual-pathway metabolic regulation. Dr. Sudderth prescribes these peptides as part of comprehensive weight management programs that include dosage titration based on patient response, metabolic monitoring, and adjustment protocols designed to minimize side effects while maximizing therapeutic benefit. Patients receive individualized treatment plans that account for their medical history, current medications, metabolic markers, and weight loss objectives.
Dr. Sudderth's background in surgery provides him with an understanding of the anatomical and physiological complications of obesity, including the metabolic syndrome components that increase surgical risk and compromise long-term health outcomes. His approach to medical weight loss incorporates this surgical perspective, recognizing when pharmacological intervention can prevent the need for bariatric procedures or optimize outcomes for patients who have previously undergone weight loss surgery. The clinic serves patients throughout Jefferson Parish and the greater New Orleans metropolitan area who require medical-grade weight loss intervention beyond commercial diet programs.
Patients at Medicus Weight Loss Clinic in Marrero receive in-person consultations that include comprehensive metabolic assessment, body composition analysis, and medical history review before beginning peptide therapy. Dr. Sudderth conducts initial evaluations to determine candidacy for semaglutide or tirzepatide based on BMI, comorbid conditions such as type 2 diabetes or hypertension, and contraindications. Follow-up appointments allow for dose adjustments, side effect management, and monitoring of weight loss progress alongside metabolic health markers. The clinic's protocol emphasizes patient education about how these peptides function, realistic expectations for weight loss timelines, and the importance of maintaining results through lifestyle modifications that support long-term metabolic health.
The clinic's location in Marrero provides accessible medical weight loss services to residents of the West Bank communities who previously had limited options for physician-supervised peptide therapy without traveling to New Orleans proper. Dr. Sudderth's surgical background and focus on medical weight loss create a unique practice model that bridges the gap between primary care weight management and bariatric surgery, offering patients a medically rigorous middle-ground option. The clinic accepts patients who meet clinical criteria for GLP-1 therapy and require ongoing medical supervision throughout their weight loss journey, with treatment plans designed for both significant weight reduction and long-term weight maintenance.
E. Ward Sudderth, M. D.· General Surgery, Cosmetic Surgery, Medical Weight Loss, Medical Director
E. Ward Sudderth, M. D.
Medical Director
General Surgery, Cosmetic Surgery, Medical Weight Loss
Cynthia Harris, FNP
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.